These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 15321838)

  • 1. Familial hypercholesterolemia and coronary heart disease: a HuGE association review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):421-9. PubMed ID: 15321838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
    Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
    Tybjaerg-Hansen A; Jensen HK; Benn M; Steffensen R; Jensen G; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):211-5. PubMed ID: 15528480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of coronary heart disease in familial hypercholesterolemia].
    Miserez AR; Keller U
    Ther Umsch; 1994 Oct; 51(10):671-6. PubMed ID: 7839323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D; Schuster H; Zöllner N
    Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
    Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
    Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
    Khoo KL; Van Acker P; Tan H; Deslypere JP
    Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL-receptor mutations in Europe.
    Dedoussis GV; Schmidt H; Genschel J
    Hum Mutat; 2004 Dec; 24(6):443-59. PubMed ID: 15523646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview.
    Hutter CM; Austin MA; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):430-5. PubMed ID: 15321839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein receptor gene mutation analysis and clinical correlation in Belgian hypercholesterolaemics.
    Van Gaal LF; Peeters AV; De Block CE; de Leeuw IH; Thiart R; Kotze MJ
    Mol Cell Probes; 2001 Dec; 15(6):329-36. PubMed ID: 11851376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
    Wang J; Huff E; Janecka L; Hegele RA
    Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.